2BB score and signals
Soleno Therapeutics, Inc.’s current 2BB score is 26 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 100 | Very Strong |
Soleno Therapeutics, Inc. (SLNO) Stock Score & Signals
Soleno Therapeutics, Inc. (SLNO) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 26 out of 100.
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-08-06 | — | 0.9563 | — | $115.12M |
| 2026-05-07 | 0.59 | 0.6936 | $94.60M | $95.29M |
| 2026-02-25 | 0.8 | 0.725 | $91.73M | $90.32M |